Depression: latest news - GoINPHARMA
Wednesday, 24 April 2019 - 17:11

Depression

Inflammation triggers depression

Depression is nowadays one of the most widespread diseases in the world. Although millions of people suffer from it, its real causes are still unknown. Neuropsychiatrist Edward Bullmore, from the University of Cambridge (UK) has proposed that depression is a…

Extensive study on depression and HIV

An increasing number of studies shows interesting links between HIV and depression. Among these, it is worth to mention a 10-year analysis (2005-2015) on 6,000 patients with HIV, with an average age of 44, which has demonstrated that risk of…

Depression and inflammation: possible link found

A study published in the review Biological Psychiatry focuses on the link between major depressive disorder (MDD) – especially in individuals with suicidal tendencies – and TSPO (translocator protein), an inflammation marker expressed in microglia. The research has been conducted…

Compass Pathways suggests new approach to treat depression

Britain-based startup Compass Pathways has requested EMA authorization to test psilocybin in a clinical trial with 400 patients in 8 countries. Psilocybin is the active ingredient contained in hallucinogenic mushrooms, and experts at Compass Pathways believe it can treat depression….

Google now offering tests to assess clinical depression

By Googling the word “depression”, users now have the opportunity to undergo a clinical test assessing their levels of depressive symptoms. The test was co-developed by the same Google and the National Alliance on Mental Illness (NAMI). There is widespread…

Extensive study on antidepressants in the US

The U.S. Center for Disease Control and Prevention published the results from an analysis on antidepressant intake in the US. The study by the US agency considers the 1999-2014 period, during which intake of antidepressants increased by 65%. Moreover, one…

Gloomy figures for depression

The World Health Organization published today, on the occasion of the World Health Day, an epidemiological study about depression. The data collected by WHO show that there are 300 million people suffering from depression in the world, an 18% increase…

Allergan confirms Botox showed efficacy in treating depression

Allergan announced on Wednesday results from a Phase II, 6-week clinical trial on 258 patients with Major Depressive Disorder treated with Botox. According to the data, the Botox 30U dose showed efficacy in treating depression. Based on the results achieved,…